| 2024年中报 | 2023年年报 | 2022年年报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 会展业务(元) | 34,052,574.42 | 67,666,819.53 | 38,163,171.25 |
| 商业运营(元) | 96,086,587.49 | 216,334,579.37 | 202,672,984.08 |
| 药品(元) | 429,740,014.81 | 995,018,401.49 | 1,038,055,917.54 |
| 医疗器械(元) | 37,719,630.24 | 72,073,059.22 | 71,618,647.24 |
| 其他(元) | 28,356,119.12 | 38,508,427.01 | 36,465,454.40 |
| 营业成本(元) | |||
| 会展业务(元) | 955,475.58 | 4,362,714.62 | 694,427.30 |
| 商业运营(元) | 21,113,894.07 | 54,085,719.25 | 47,448,233.32 |
| 药品(元) | 239,483,351.26 | 444,089,318.14 | 429,876,491.93 |
| 医疗器械(元) | 6,205,892.72 | 9,200,242.88 | 10,821,623.94 |
| 其他(元) | 11,780,145.79 | 21,300,520.35 | 20,271,270.07 |
| 毛利(元) | |||
| 会展业务(元) | 33,097,098.84 | 63,304,104.91 | 37,468,743.95 |
| 商业运营(元) | 74,972,693.42 | 162,248,860.12 | 155,224,750.76 |
| 药品(元) | 190,256,663.55 | 550,929,083.35 | 608,179,425.61 |
| 医疗器械(元) | 31,513,737.52 | 62,872,816.34 | 60,797,023.30 |
| 其他(元) | 16,575,973.33 | 17,207,906.66 | 16,194,184.33 |
| 毛利率(%) | |||
| 会展业务(%) | 97.19 | 93.55 | 98.18 |
| 商业运营(%) | 78.03 | 75.00 | 76.59 |
| 药品(%) | 44.27 | 55.37 | 58.59 |
| 医疗器械(%) | 83.55 | 87.23 | 84.89 |
| 其他(%) | 58.46 | 44.69 | 44.41 |
| 收入构成(%) | |||
| 会展业务(%) | 5.44 | 4.87 | 2.75 |
| 商业运营(%) | 15.35 | 15.57 | 14.61 |
| 药品(%) | 68.65 | 71.60 | 74.84 |
| 医疗器械(%) | 6.03 | 5.19 | 5.16 |
| 其他(%) | 4.53 | 2.77 | 2.63 |
| 毛利构成(%) | |||
| 会展业务(%) | 9.55 | 7.39 | 4.27 |
| 商业运营(%) | 21.64 | 18.94 | 17.68 |
| 药品(%) | 54.92 | 64.32 | 69.28 |
| 医疗器械(%) | 9.10 | 7.34 | 6.93 |
| 其他(%) | 4.78 | 2.01 | 1.84 |